FdaApplication
BLA 761033
Identifiers
- fda_app_no: BLA761033
Properties
| Property | Value |
|---|---|
| applicant_name | Teva Respiratory, LLC |
| application_type | BLA |
| approval_date | 2016-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CINQAIR | RESLIZUMAB | 100MG/10ML (10MG/ML) | Injection |
1 product